The 9th edition of Global Pharma Regulatory Summit goes Virtual

Since our last announcement regarding postponing the 9th edition of Global Pharma Regulatory Summit in April, COVID-19 continues to affect travel and business worldwide. Therefore, Informa Markets in India, organizer of Global Pharma Regulatory Summit has taken the decision to change the event format. The three-day summit, which was scheduled from 19th –21st August 2020,has now been condensed to a two-day virtual summit on 20th- 21st August 2020.

The decision of transforming the event to a virtual format has been received positively by the industry and allows industry professionals and experts to continue engaging as before. The Global Pharma Regulatory Summit team will reach out to all participants regarding detailed arrangements in due course.

We wish to thank you for supporting Global Pharma Regulatory Summit and greatly appreciate your patience and understanding. Our sole focus remains to provide an event of enhanced quality, with more Industry professionals to make your participation a huge success. We look forward to your virtual participation at the re-scheduled dates for the summit.

For additional questions, comments, and concerns please contact:

For Partnership & Speaking enquiries, please email
For Content enquiries, please email
For Delegate inquiry, please email
For Marketing inquiry, please email

Industry Landscape

Globally, Indian pharma has contributed to improve public health outcomes. India accounts for 60% of global vaccine production, contributing 40 to 70% of the WHO demand for Diphtheria, Tetanus and Pertussis (DPT) and Bacillus Calmette–Guérin (BCG) vaccines, and 90% of the WHO demand for the measles vaccine. Estimates suggest that one in every three pills consumed in the United States is produced by an Indian generics manufacturer. In the UK, approximately 25% of the medicines used are made in India.

Why this Forum

The 9th Edition Global Pharma Regulatory Summit organized by CPhI Conferences will witness a gathering of senior leaders and experts of regulatory affairs, compliances, quality assurance and policy makers to discuss and share their perspectives on current trends and challenges in global regulatory landscape. The themes are designed to inspire and enable the brilliant minds from across the pharma ecosystem to come together to examine, discuss and debate how to improve regulatory system and lower the challenges associated

Who Should Partner

Enterprise Solutions

Regulatory solutions
Regulatory solutions
Legal firms
Legal firms
Pharma consultants
Pharma consultants
Data management
Data management
Software and technology
Software and technology
R&D solution providers
R&D solution providers

Who Should Attend?

The 9th Global Pharma Regulatory Summit will bring together leading Regulatory experts and decision makers from across the pharma industry. These delegates will be attending this summit to learn about the latest updates on regulations, best practice and compliance advances in the sector and much more.


VP’s; Directors; HODs
Sr. Managers / General Managers
Managers/ Deputy Managers

Programme Focus

Advisory Board Members & Speakers

Why Attend

Access the latest information and insights on global regulatory affairs program

Analyze how stakeholders around the world are supporting regulatory system optimization

Examine the impact of new initiatives for emerging markets

Network with innovators and opinion leaders in the pharma regulatory affairs arena

Glimpses & Testimonials



Full speaker list • Full conference agenda


Full speaker list


Full speaker list